Health Articles

RSS

Causes of Multiple System Atrophy

The fundamental cause of multiple system atrophy (MSA) is a loss of oligodendroglial and neuronal cells in the brain and central nervous system. The loss of cells is gradual and progressive, leading to slowly worsening symptoms.

10 Aug 2016

Multiple System Atrophy Treatment

People with multiple system atrophy (MSA) generally have a very poor prognosis. Their median survival is 6.2 to 9.5 years after the first symptoms appear. Patients who are older at the time of onset tend to have a shorter survival time. There are no therapies that cure or alter the disease or slow its progress, but there are many treatments available which may alleviate the symptoms of MSA.

10 Aug 2016

Multiple System Atrophy (MSA)

10 Aug 2016

Types of Multiple Sclerosis (MS)

Multiple sclerosis (MS) is a neurological disease affecting millions of people worldwide. It is a condition affecting the central nervous system (CNS) which comprises the brain and the spinal cord. In this condition, the immune system of the body attacks myelin, the protective sheath covering nerve fibers in the CNS. This leads to communication issues between the brain and the body and eventually results in irreversible damage to the nerves.

9 Aug 2016

Benign Multiple Sclerosis (MS)

Benign multiple sclerosis (MS) is a mild course of MS seen in 5-10% of MS patients. In people affected by benign MS, there is no worsening of functional ability even after 15 years of diagnosis. Currently, there is no way of predicting this form of MS at the time of diagnosis.

9 Aug 2016

Secondary Progressive Multiple Sclerosis (SPMS)

Secondary progressive multiple sclerosis (SPMS) is a form of MS that typically follows relapsing-remitting MS (RRMS). It is characterized by steady accumulation of disability without relapses.

9 Aug 2016

Relapsing-Remitting Multiple Sclerosis (RRMS)

Relapsing-remitting multiple sclerosis (RRMS) is found in about 85% of people diagnosed with MS and is the most common disease course.

9 Aug 2016

Primary Progressive Multiple Sclerosis (PPMS)

Primary progressive multiple sclerosis (PPMS) is an uncommon form of MS that affects approximately 10-15% of MS patients. In PPMS, symptoms steadily get worse over time without frequent relapses or remission.

9 Aug 2016

Phases of Chronic Myeloid Leukemia

Chronic myeloid leukemia (CML) is a type of cancer that begins in the cells in the bone marrow that are involved in the production of blood cells. The condition can be classified into 3 main phases according to specific characteristics, which helps to guide treatment decisions.

9 Aug 2016

Chronic Myeloid Leukemia Pathophysiology

The pathophysiology of chronic myeloid leukemia (CML) is important to understand so that we can tailor treatments to the specific characteristic of the disease. This helps to improve treatment outcomes and minimize general side effects of therapy, as targeted treatments for the condition can be introduced.

9 Aug 2016

Chronic Myeloid Leukemia Treatment

There are several other treatment methods that may be used to manage symptoms and prevent progression of chronic myeloid leukemia (CML), such as tyrosine kinase inhibitors, myelosuppressive therapy, splenectomy, and interferon alfa-2b treatment. It can also be cured with a bone marrow or allogeneic stem cell transplant.

9 Aug 2016

What Causes Goodpasture Syndrome?

Goodpasture syndrome is an autoimmune disorder which involves destruction of the glomerular and pulmonary alveolar basement membrane. The glomeruli are part of the filtering apparatus of the nephrons - the tiny units of the kidney. These are coiled loops of capillaries which filter out water and solutes from the blood passing through them. When the basement membrane is damaged by the autoantibodies formed in Goodpasture syndrome, glomerular cell proliferation occurs in response to cell-mediated immune responses, leading to the acute loss of renal function.

9 Aug 2016

Goodpasture Syndrome Treatment

Goodpasture syndrome requires early and effective treatment if it is not to be fatal. The regimens in use have decreased the mortality rate from the original 96% to less than 20%.

9 Aug 2016

Goodpasture Syndrome

Goodpasture syndrome is a condition characterized by renal and pulmonary symptoms due to the presence of anti-GBM antibodies.

9 Aug 2016

Pulmonary Resection in Lung Cancer

Pulmonary resection is the first line of treatment of stage I and II non-small cell lung cancer (NSCLC). It is also important as part of the management of stage IIIA. In early stages of NSCLC, the surgery focuses on diagnosis, staging and resection of the entire tumor. Pneumonectomy and lobectomy carry a mortality rate in hospital of up to 4% and 8% percent respectively.

8 Aug 2016

Oral Allergy Syndrome (OAS)

Oral allergy syndrome (OAS) is also called “pollen-food allergy syndrome,” “pollen-food syndrome,” and “pollen-associated food allergy syndrome”. It is among the most common types of food allergy.

8 Aug 2016

Pediatric Nursing

Pediatric nursing is a specialization of the nursing profession that focuses on pediatrics and the medical care of children, from infancy to the teenage years. This is an important field because the health of children is distinct from that of adults due to the growth and development that occurs throughout childhood.

8 Aug 2016

Breath-Holding Spells in Children

Breath-holding spells are an involuntary reflex that commonly occurs among children, especially those aged under six years. They occur in around 5% of otherwise healthy children. They are most common during the child’s second year of life and are more likely to affect children who have a family history of them.

8 Aug 2016

Cutaneous Vasculitis

Vasculitis is an inflammatory disorder which affects the wall of blood vessels in the skin. It may be classified based on the type of vessel involved, as small vessel, medium-vessel and large vessel vasculitis.

8 Aug 2016

What is Pharmacoepidemiology?

The science of pharmacoepidemiology can answer a range of questions regarding how, why, when, where, and by whom a medicine is being used. It is a way of finding out the impact of a medicine as well as the usage results in a large, well-defined population. Also, it can help provide some indication as to how a particular drug is benefitting society and how it may be having a negative impact. Pharmacoepidemiology can be carried out both before and after a medicine is taken to market.

8 Aug 2016